✦ LIBER ✦

Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes

✍ Scribed by Patricia Alvarez-Muñoz; Michael Mauer; Youngki Kim; Stephen S. Rich; Michael E. Miller; Gregory B. Russell; José M. Lopez-Novoa; M. Luiza Caramori

Book ID: 113699854
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 190 KB
Volume: 24
Category: Article
ISSN: 1056-8727
DOI: 10.1016/j.jdiacomp.2009.03.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cellular basis of diabetic nephropathy:

Cellular basis of diabetic nephropathy: III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in Type 1 diabetic patients

✍ C. Huang; Y. Kim; M. L. Caramori; A. J. Fish; S. S. Rich; M. E. Miller; G. B. Ru 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 175 KB

Telomere length and progression of diabe

Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes

✍ F. Fyhrquist; A. Tiitu; O. Saijonmaa; C. Forsblom; P.-H. Groop; on behalf of the 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Maternal history of type 2 diabetes is a

Maternal history of type 2 diabetes is associated with diabetic nephropathy in type 1 diabetic patients

✍ S. Hadjadj; F. Duengler; F. Torremocha; G. Faure-Gerard; F. Bridoux; M. Boissonn 📂 Article 📅 2007 🏛 Masson Editeur 🌐 French ⚖ 257 KB

Prevalence of diabetic retinopathy and d

Prevalence of diabetic retinopathy and diabetic neuropathy in patients with diabetes mellitus type 2 and diabetic nephropathy

✍ M. Koselj; M. Koselj-Kajtna 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Cardiovascular outcomes in the Irbesarta

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy

✍ T. Berl; L.G. Hunsicker; J.B. Lewis 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Effects of acetazolamide on kidney funct

Effects of acetazolamide on kidney function in Type 1 (insulin-dependent) diabetic patients with diabetic nephropathy

✍ P. Skøtt; E. Hommel; N. E. Bruun; S. Arnold-Larsen; H. -H. Parving 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 582 KB

We investigated the effects of 3 days treatment with acetazolamide 250 mg three times daily on kidney function in 8 Type 1 (insulin-dependent) diabetic patients with nephropathy, and in 7 healthy subjects in a double-blind placebo controlled cross-over study. Glomerular filtration rate and extracell